Institutional Ownership Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM). We have compiled data on the 67 institutions that hold shares in the stock, with a total of 44.3 Million shares, which have been reported (via 13F filing form) to have a value of $182 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2025 Q3 2025 |
109,300
shares
|
$449,223
0.01% of portfolio
|
Q3 2025
Reduced 18.62%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
103,100
shares
|
$423,741
0.0% of portfolio
|
Q2 2025
Reduced 72.76%
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
89,400
shares
|
$367,434
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
86,334
shares
|
$354,832
0.0% of portfolio
|
Q3 2025
Reduced 13.2%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
80,900
shares
|
$332,499
0.0% of portfolio
|
Q3 2025
Reduced 14.75%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
79,654
shares
|
$327,377
0.0% of portfolio
|
Q3 2025
Reduced 46.25%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
73,715
shares
|
$302,968
0.0% of portfolio
|
Q3 2025
Reduced 63.38%
|
|
|
Lpl Financial LLC
Fort Mill, SC |
Nov 12, 2025 Q3 2025 |
61,000
shares
|
$250,710
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Citizens Financial Group Inc
|
Oct 24, 2025 Q3 2025 |
46,000
shares
|
$189,060
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Prelude Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
40,718
shares
|
$167,350
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
39,034
shares
|
$160,429
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
38,900
shares
|
$159,879
0.0% of portfolio
|
Q2 2025
Reduced 3.05%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
38,591
shares
|
$158,609
0.0% of portfolio
|
Q3 2025
Reduced 37.93%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
36,602
shares
|
$150,434
0.0% of portfolio
|
Q3 2025
Added 6.68%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
29,184
shares
|
$119,946
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Persistent Asset Partners LTD
Hong Kong, K3 |
Nov 10, 2025 Q3 2025 |
28,221
shares
|
$115,988
0.04% of portfolio
|
Q3 2025
Reduced 80.56%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
24,753
shares
|
$101,734
0.0% of portfolio
|
Q3 2025
Reduced 15.74%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
22,600
shares
|
$92,886
0.0% of portfolio
|
Q3 2025
Added 7561.02%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
22,012
shares
|
$90,469
0.0% of portfolio
|
Q3 2025
Reduced 92.82%
|
|
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
18,272
shares
|
$75,097
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
17,699
shares
|
$72,742
0.0% of portfolio
|
Q3 2025
Reduced 9.88%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2025 Q3 2025 |
15,000
shares
|
$61,650
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Vanguard Personalized Indexing Management, LLC
Oakland, CA |
Oct 31, 2025 Q3 2025 |
14,546
shares
|
$59,784
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2025 Q3 2025 |
13,244
shares
|
$54,432
0.0% of portfolio
|
Q3 2025
Reduced 6.08%
|
|
|
Hsbc Holdings PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
11,944
shares
|
$49,089
0.0% of portfolio
|
Q3 2025
Reduced 10.17%
|
|